Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magali Colombat

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 24, 2015
(99m)Tc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosisArnault Galat, Axel Van Der Gucht, Magali Colombat, et al.
Transplantation|June 24, 2006
Thrombotic microangiopathy with acquired deficiency in ADAMTS 13 activity in lung transplant recipientsHervé Mal, Agnès Veyradier, Olivier Brugière, et al.
Clinical Kidney Journal|March 7, 2025
CD163 detection in immune check-point inhibitors-related acute interstitial nephritisThomas Perier, Yves Renaudineau, Juliette Pellegrini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2017
Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosisFabien Le Bras, Valerie Molinier-Frenkel, Aziz Guellich, et al.
Journal of Medical Case Reports|August 14, 2017
Vitreous amyloidosis with autonomic neuropathy of the digestive tract associated with a novel transthyretin p.Gly87Arg variant in a Bangladeshi patient: a case reportBenjamin Terrier, Magali Colombat, Caroline Beugnet, et al.
Clinical Transplantation|August 2, 2019
Anti-IL-2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid-term outcomes after ABO-incompatible kidney transplantationArnaud Del Bello, Gillian Divard, Julie Belliere, et al.
Journal of Translational Autoimmunity|October 25, 2023
Are serum C3 levels or kidney C3 deposits useful markers for predicting outcomes in patients with ANCA-associated vasculitis?Alexis Cassard, Clément Kounde, Laurence Bouillet, et al.
Kidney International Reports|July 13, 2023
Randall-Type Monoclonal IgE Kappa Light-Heavy Chain Deposition DiseasePierre Isnard, Nicolas Benichou, David Sibon, et al.
Transplant Immunology|March 20, 2026
Anti-lymphocyte globulin versus anti-thymocyte globulin in kidney transplant patients with preformed donor specific antibodiesNassim Kamar, Nicolas Congy-Jolivet, Sofiane Salhi, et al.
Journal of Clinical Medicine|February 15, 2022
Spectrum of Kidney Disorders Associated with T-Cell ImmunoclonesAlexis Piedrafita, François Vergez, Julie Belliere, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 24, 2015
(99m)Tc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosisArnault Galat, Axel Van Der Gucht, Magali Colombat, et al.
Transplantation|June 24, 2006
Thrombotic microangiopathy with acquired deficiency in ADAMTS 13 activity in lung transplant recipientsHervé Mal, Agnès Veyradier, Olivier Brugière, et al.
Clinical Kidney Journal|March 7, 2025
CD163 detection in immune check-point inhibitors-related acute interstitial nephritisThomas Perier, Yves Renaudineau, Juliette Pellegrini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2017
Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosisFabien Le Bras, Valerie Molinier-Frenkel, Aziz Guellich, et al.
Journal of Medical Case Reports|August 14, 2017
Vitreous amyloidosis with autonomic neuropathy of the digestive tract associated with a novel transthyretin p.Gly87Arg variant in a Bangladeshi patient: a case reportBenjamin Terrier, Magali Colombat, Caroline Beugnet, et al.
Clinical Transplantation|August 2, 2019
Anti-IL-2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid-term outcomes after ABO-incompatible kidney transplantationArnaud Del Bello, Gillian Divard, Julie Belliere, et al.
Journal of Translational Autoimmunity|October 25, 2023
Are serum C3 levels or kidney C3 deposits useful markers for predicting outcomes in patients with ANCA-associated vasculitis?Alexis Cassard, Clément Kounde, Laurence Bouillet, et al.
Kidney International Reports|July 13, 2023
Randall-Type Monoclonal IgE Kappa Light-Heavy Chain Deposition DiseasePierre Isnard, Nicolas Benichou, David Sibon, et al.
Transplant Immunology|March 20, 2026
Anti-lymphocyte globulin versus anti-thymocyte globulin in kidney transplant patients with preformed donor specific antibodiesNassim Kamar, Nicolas Congy-Jolivet, Sofiane Salhi, et al.
Journal of Clinical Medicine|February 15, 2022
Spectrum of Kidney Disorders Associated with T-Cell ImmunoclonesAlexis Piedrafita, François Vergez, Julie Belliere, et al.
Pageof 9